{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:17:27Z","timestamp":1769221047169,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jchromb.2024.124038","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T21:01:50Z","timestamp":1707253310000},"page":"124038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A validated LC-MS\/MS method for determination of six Anti-SARS-CoV-2 drugs in plasma and its application for a pharmacokinetic study in rats"],"prefix":"10.1016","volume":"1235","author":[{"given":"Zong-liang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124038_b0005","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/jmv.27561","article-title":"Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario","volume":"94","author":"Mohapatra","year":"2022","journal-title":"J. Medical Virology"},{"key":"10.1016\/j.jchromb.2024.124038_b0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ijid.2020.03.070","article-title":"Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China","volume":"95","author":"Wang","year":"2020","journal-title":"International journal of infectious diseases"},{"key":"10.1016\/j.jchromb.2024.124038_b0015","doi-asserted-by":"crossref","first-page":"e28443","DOI":"10.1002\/jmv.28443","article-title":"Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS-CoV-2 Omicron variants","volume":"95","author":"Wang","year":"2023","journal-title":"J. Medical Virology."},{"key":"10.1016\/j.jchromb.2024.124038_b0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/d41586-022-00220-5","article-title":"COVID-19: LMICs need antivirals as well as vaccines","volume":"602","author":"Bajaj","year":"2022","journal-title":"Nature."},{"key":"10.1016\/j.jchromb.2024.124038_b0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s41043-023-00422-1","article-title":"Impacts of the COVID-19 pandemic on Chinese assisted reproductive technology institutions and human sperm banks: reflections in the post-pandemic era","volume":"42","author":"Wei","year":"2023","journal-title":"J. Health, Population, and Nutrition"},{"key":"10.1016\/j.jchromb.2024.124038_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/v14050961","article-title":"Antiviral drug discovery for the treatment of COVID-19 Infections","volume":"14","author":"Ng","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jchromb.2024.124038_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/v14010079","article-title":"SARS-CoV-2 T cell responses elicited by COVID-19 vaccines or infection are expected to remain robust against omicron","volume":"14","author":"Ahmed","year":"2022","journal-title":"Viruses."},{"key":"10.1016\/j.jchromb.2024.124038_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/v14010078","article-title":"The remarkable evolutionary plasticity of coronaviruses by mutation and recombination: insights for the COVID-19 pandemic and the future evolutionary paths of SARS-CoV-2","volume":"14","author":"Amoutzias","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.jchromb.2024.124038_b0045","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1021\/acs.molpharmaceut.2c00383","article-title":"Recent advances in targeted nanotherapies for ischemic stroke","volume":"19","author":"Liao","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jchromb.2024.124038_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.109149","article-title":"Advanced nano drug delivery systems for neuroprotection against ischemic stroke","volume":"35","author":"Xie","year":"2024","journal-title":"Chinese Chemical Letters."},{"key":"10.1016\/j.jchromb.2024.124038_b0055","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1016\/j.apsb.2022.09.002","article-title":"Research and development of Chinese anti-COVID-19 drugs","volume":"12","author":"Ji","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.jchromb.2024.124038_b0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40265-022-01692-5","article-title":"Nirmatrelvir plus ritonavir: first approval","volume":"82","author":"Lamb","year":"2022","journal-title":"Drugs."},{"key":"10.1016\/j.jchromb.2024.124038_b0065","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An Oral SARS-CoV-2 m(pro) Inhibitor Clinical Candidate for the Treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jchromb.2024.124038_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanwpc.2023.100835","article-title":"Efficacy and safety of SIM0417 (SSD8432) plus ritonavir for COVID-19 treatment: a randomised, double-blind, placebo-controlled, phase 1b trial","volume":"38","author":"Wang","year":"2023","journal-title":"The Lancet Regional Health. Western Pacific"},{"key":"10.1016\/j.jchromb.2024.124038_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102189","article-title":"Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial","volume":"63","author":"Wang","year":"2023","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.jchromb.2024.124038_b0080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41392-021-00835-6","article-title":"Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jchromb.2024.124038_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202001435","article-title":"Open-Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, a Pilot Study","volume":"7","author":"Ren","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jchromb.2024.124038_b0090","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jchromb.2024.124038_b0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cid\/ciac180","article-title":"Molnupiravir and nirmatrelvir-ritonavir: oral coronavirus disease 2019 antiviral drugs","volume":"76","author":"Saravolatz","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2024.124038_b0100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2208822","article-title":"VV116 versus nirmatrelvir-ritonavir for oral treatment of Covid-19","volume":"388","author":"Cao","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jchromb.2024.124038_b0105","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1080\/22221751.2022.2078230","article-title":"An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants","volume":"11","author":"Shen","year":"2022","journal-title":"Emerging Microbes Infect."},{"key":"10.1016\/j.jchromb.2024.124038_b0110","doi-asserted-by":"crossref","first-page":"e5456","DOI":"10.1002\/bmc.5456","article-title":"Simultaneous determination of nirmatrelvir and ritonavir in human plasma using LC-MS\/MS and its pharmacokinetic application in healthy Chinese volunteers","volume":"36","author":"Liu","year":"2022","journal-title":"Biomedical Chromatography : BMC."},{"key":"10.1016\/j.jchromb.2024.124038_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115340","article-title":"Characterization of in-vivo human metabolites of the oral nucleoside anti-COVID-19 drug VV116 using UHPLC-Orbitrap-MS","volume":"228","author":"Zhou","year":"2023","journal-title":"J. Pharmaceutical and Biomedical Analysis."},{"key":"10.1016\/j.jchromb.2024.124038_b0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpba.2014.06.019","article-title":"Quantification of 2'-deoxy-2'-\u03b2-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: application to bioavailability and pharmacokinetic studies","volume":"98","author":"Peng","year":"2014","journal-title":"J. Pharmaceutical and Biomedical Analysis."},{"key":"10.1016\/j.jchromb.2024.124038_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123363","article-title":"A validated LC-MS\/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers","volume":"1206","author":"Gouda","year":"2022","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124038_b0130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jconrel.2023.05.009","article-title":"Recent advances in biomimetic nanodelivery systems: new brain-targeting strategies","volume":"358","author":"Liao","year":"2023","journal-title":"J. Controlled Release: Official J. the Controlled. Release. Society."},{"key":"10.1016\/j.jchromb.2024.124038_b0135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4155\/bio.13.52","article-title":"Recent advances in unique sample preparation techniques for bioanalysis","volume":"5","author":"Namera","year":"2013","journal-title":"Bioanalysis."},{"key":"10.1016\/j.jchromb.2024.124038_b0140","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4155\/bio.14.118","article-title":"Biological sample preparation: attempts on productivity increasing in bioanalysis","volume":"6","author":"Soltani","year":"2014","journal-title":"Bioanalysis."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224000461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:56Z","timestamp":1761606776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224000461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S1570023224000461"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124038","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A validated LC-MS\/MS method for determination of six Anti-SARS-CoV-2 drugs in plasma and its application for a pharmacokinetic study in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124038"}}